Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study

Heparins and vitamin K antagonists are the mainstay of treatment of splanchnic vein thrombosis (SVT). Rivaroxaban is a potential alternative, but data to support its use are limited. We aimed to evaluate the safety and efficacy of rivaroxaban for the treatment of acute SVT. In an international, sing...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood advances 2022-06, Vol.6 (12), p.3569-3578
Hauptverfasser:	Ageno, Walter, Beyer Westendorf, Jan, Contino, Laura, Bucherini, Eugenio, Sartori, Maria Teresa, Senzolo, Marco, Grandone, Elvira, Santoro, Rita, Carrier, Marc, Delluc, Aurélien, De Stefano, Valerio, Pomero, Fulvio, Donadini, Marco Paolo, Tosetto, Alberto, Becattini, Cecilia, Martinelli, Ida, Nardo, Barbara, Bertoletti, Laurent, Di Nisio, Marcello, Lazo-Langner, Alejandro, Schenone, Alessandro, Riva, Nicoletta
Format:	Artikel
Sprache:	eng
Schlagworte:	Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!